CannTrust Slides After Auditor KPMG Withdraws Financial Report

CannTrust Slides After Auditor KPMG Withdraws Financial Report

CannTrust says 'newly uncovered information' from its own special committee's investigation calls into question the validity of its financial statements.

Is Cannabis Legislation Closer Than You Think?

Is Cannabis Legislation Closer Than You Think?

Common sense should prevail when it comes to legislation, according to this cannabis executive.

Canopy Growth to Buy Beckley Canopy Therapeutics

Canopy Growth to Buy Beckley Canopy Therapeutics

Canopy Growth agrees to buy Beckley Canopy Therapeutics, a joint venture it initially launched in 2018 to research and develop cannabis-based medicines.

Ask The Expert: Cannabis One CEO Believes Now Is the Time to Invest in Cannabis

Ask The Expert: Cannabis One CEO Believes Now Is the Time to Invest in Cannabis

The recent selloff is a great opportunity to buy in, according to Cannabis One's CEO.

The Rally in GW Pharmaceuticals Should Continue - Here's How I'd Play It

The Rally in GW Pharmaceuticals Should Continue - Here's How I'd Play It

Let's see how the charts of GWPH are shaping up.

Cronos Lights Up on Strong Second-Quarter Earnings

Cronos Lights Up on Strong Second-Quarter Earnings

Shares of Canadian cannabis producer and distributor Cronos rise after the company reports second-quarter earnings that exceed analysts' forecasts amid ongoing demand for its marijuana-infused products.

Canopy Growth Signs Exclusive Vaporizer Deal With Greenlane

Canopy Growth Signs Exclusive Vaporizer Deal With Greenlane

Greenlane has exclusive U.S. distribution rights for Canopy Growth's Storz & Bickel vaporizers.

Tea Maker AriZona Teams Up With Dixie Brands for Cannabis-Infused Drink

Tea Maker AriZona Teams Up With Dixie Brands for Cannabis-Infused Drink

AriZona's subsidiary Herbal Enterprises will direct brand and product conceptual design.

GW Pharma Surges on Marijuana-Based Epilepsy Drug Sales, Analyst Upgrades

GW Pharma Surges on Marijuana-Based Epilepsy Drug Sales, Analyst Upgrades

Shares of GW Pharmaceuticals surge following soaring sales of its marijuana-derived epilepsy drug that prompts two analysts to raise their stock-price targets.

Green Organic Dutchman Files for Nasdaq Listing

Green Organic Dutchman Files for Nasdaq Listing

Green Organic Dutchman files an application to be listed on the Nasdaq Stock Market.